Karl Martin Erik Åmark

Filings at 1 company/Chief executive officer · Xbrane Biopharma AB

5 of 43 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 43. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 43 visible filings, newest first.

Xbrane Biopharma AB Chief executive officer
315,054 SEKOpen-market sale
TradedJan 17, 2025FiledJan 20, 2025
Xbrane Biopharma AB Chief executive officer
318,782 SEKOpen-market buy
TradedJan 17, 2025FiledJan 20, 2025
Xbrane Biopharma AB Chief executive officer
256,500 SEKOpen-market buy
TradedJan 16, 2025FiledJan 20, 2025
Xbrane Biopharma AB Chief executive officer
256,500 SEKOpen-market sale
TradedJan 16, 2025FiledJan 20, 2025
Xbrane Biopharma AB Chief executive officer
129,000 SEKOpen-market buy
TradedSep 12, 2023FiledSep 12, 2023